Indole

Indole

SCHEMBL2059954

CCN.c1ccc2[nH]ccc2c1

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 7/20 0.74
TRPA1 O75762 1/20 0.74
CA1 P00915 1/20 0.74
CA2 P00918 1/20 0.74
ITGB2 P05107 1/20 0.74
ICAM1 P05362 1/20 0.74
ITGAL P20701 1/20 0.74
CA4 P22748 1/20 0.74
CA6 P23280 1/20 0.74
ADK P55263 1/20 0.74
NPC1 O15118 1/20 0.42
LOXL2 Q9Y4K0 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MEN1 O00255 1/20 0.38
POLB P06746 1/20 0.38
MAPK1 P28482 1/20 0.38
KMT2A Q03164 1/20 0.38
NR4A2 P43354 2/20 0.38
CTNNB1 P35222 2/20 0.38
WNT3A P56704 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Indole SCHEMBL27922533 0.91 AHR (0.81) AHRTRPA1CA1CA2ITGB2
Indole SCHEMBL28087845 0.89 AHR (0.77) AHRTRPA1CA1CA2ITGB2
Indole SCHEMBL28042366 0.89 AHR (0.85) AHRTRPA1CA1CA2ITGB2
Indole SCHEMBL28020016 0.89 AHR (0.85) AHRTRPA1CA1CA2ITGB2
Indole SCHEMBL28385617 0.87 AHR (0.74) AHRTRPA1CA1CA2ITGB2
Indole SCHEMBL28306370 0.87 AHR (0.74) AHRTRPA1CA1CA2ITGB2
Indole SCHEMBL399069 0.87 AHR (0.74) AHRTRPA1CA1CA2ITGB2
Indole SCHEMBL27957692 0.86 AHR (0.90) AHRTRPA1CA1CA2ITGB2
Indole SCHEMBL30463845 0.86
Indole SCHEMBL29352896 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117486777-A Indoloethylamine derivative and preparation method and application thereof 浙江中医药大学 2024-02-02 CN claimed
US-20110159068-A1 Osteogenic composition comprising a growth factor/amphiphilic polymer complex, a soluble cation salt and an organic support ADOCIA (FR) 2011-06-30 US claimed
US-20090291114-A1 OSTEOGENIC COMPOSITION COMPRISING A GROWTH FACTOR/AMPHIPHILIC POLYMER COMPLEX, A SOLUBLE CATION SALT AND AN ORGANIC SUPPORT ADOCIA (FR) 2009-11-26 US claimed
CN-119798255-A 1-Thienyl-beta-carboline IDO1 and TDO dual inhibitor and medical application thereof 南京医科大学 2025-04-11 CN disclosed
CN-117486777-A Indoloethylamine derivative and preparation method and application thereof 浙江中医药大学 2024-02-02 CN disclosed
CN-100420672-C Selective COX-2 inhibitory novel esters from indolealkanols and novel amides from indolealkylamines UNIV VANDERBILT (US) 2008-09-24 CN disclosed
CN-100418968-C Pirazino(aza)indole derivatives VERNALIS RES LTD (GB) 2008-09-17 CN disclosed
CN-1289499-C Pyrazino (aza) indole derivatives VERNALIS RES LTD (GB) 2006-12-13 CN disclosed
US-7145009-B2 Pirazino(aza)indole derivatives VERNALIS RESEARCH LIMITED (GB) 2006-12-05 US disclosed
CN-1837207-A Pirazino(aza)indole derivatives VERNALIS RES LTD (GB) 2006-09-27 CN disclosed
US-20060160816-A1 Pirazino(AZA) indole derivatives VERNALIS RESEARCH LIMITED 2006-07-20 US disclosed
EP-0623138-A1 NEW ADENOSINE DERIVATIVES, PREPARATION METHODS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. UNION PHARMA SCIENT APPL (FR) 1994-11-09 EP disclosed
WO-1994023720-A1 TETRAHYDRO-BETA-CARBOLINES ELI LILLY AND COMPANY (US) 1994-10-27 WO disclosed
WO-1994024132-A1 TETRAHYDRO-PYRIDO-INDOLE ELI LILLY AND COMPANY (US) 1994-10-27 WO disclosed
EP-0620223-A2 Tetrahydro-pyrido-indole ELI LILLY AND COMPANY (US) 1994-10-19 EP disclosed
EP-0620222-A2 Tetrahydro-beta-carbolines ELI LILLY AND COMPANY (US) 1994-10-19 EP disclosed
US-5300645-A Condensation of cycloalkyl-, phenyl- or naphthylpyrrole ethylamines with a 2-oxazolidinone to get antiserotonine agent ELI LILLY AND COMPANY (US) 1994-04-05 US disclosed
WO-1993014102-A1 NEW ADENOSINE DERIVATIVES, PREPARATION METHODS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM LABORATOIRES UPSA (FR) 1993-07-22 WO disclosed
CN-1015054-B N-INDOLYLETHYL SULPHONIC ACID AMIDES, PROCESS FOR PREPARATION THEREOF AND THEIR USE BAYER AG (DE) 1991-12-11 CN disclosed
CN-86102761-A N-indyl ethyl-sulfonamides Preparation Method And The Use 1987-02-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291114-A1 OSTEOGENIC COMPOSITION COMPRISING A GROWTH FACTOR/AMPHIPHILIC POLYMER COMPLEX, A SOLUBLE CATION SALT AND AN ORGANIC SUPPORT BMP2, SOST, BMP1 AHR 3378/4885TRPA1 3200/4885CA1 62/4885
US-20060160816-A1 Pirazino(AZA) indole derivatives PIR, GPR119, INMT AHR 51/4885TRPA1 338/4885CA1 1874/4885
US-20110159068-A1 Osteogenic composition comprising a growth factor/amphiphilic polymer complex, a soluble cation salt and an organic support BMP2, SOST, BMP1 AHR 3677/4885TRPA1 2965/4885CA1 89/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.